COVID-19 x ray: Difference between revisions
No edit summary |
No edit summary |
||
Line 71: | Line 71: | ||
|35.4 | |35.4 | ||
|- | |- | ||
|Other findings | | rowspan="2" |Other findings | ||
|Lymphadenopathy | |Lymphadenopathy | ||
|0.3 | |0.3 | ||
|- | |- | ||
|Effusion | |Effusion | ||
|0.3 | |0.3 |
Revision as of 14:23, 13 July 2020
For COVID-19 frequently asked inpatient questions, click here
For COVID-19 frequently asked outpatient questions, click here
COVID-19 Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
COVID-19 x ray On the Web |
American Roentgen Ray Society Images of COVID-19 x ray |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
An x-ray may be helpful in the diagnosis of COVID-19 infection. Findings of chest x-ray can be consistent with the disease severity and time of presentation. Chest X-ray findings of covid-19 may be normal in early/mild disease. Findings are most extensive about 10-12 days after symptom onset. The most frequent findings are consolidation. The distribution is most often bilateral, peripheral, and lower zone predominant. In contrast to parenchymal disease, pleural effusion is rare.
X Ray
- An x-ray may be helpful in the diagnosis of COVID-19 infection.
- Findings of chest x-ray can be consistent with the disease severity and time of presentation.
- Chest X-ray findings of Covid-19 may be normal in early/mild disease.
- Findings are most extensive about 10-12 days after symptom onset.
- Findings on X-ray in severe COVID-19 infection include:
- Airspace opacities (consolidation)
- Often bilateral, peripheral, and lower zone predominant.
- Airspace opacities (consolidation)
- Pleural effusions are rare.
Radiologic Pattern | Categories | % of individuals |
---|---|---|
Severity | Normal | 58.3 |
Mild | 30.7 | |
Moderate | 10.2 | |
Severe | 0.8 | |
Type of Infiltrate | Interstitial | 23.7 |
Ground glass opacities | 18.9 | |
Consolidation | 5.3 | |
Location | Lower | 33.8 |
Upper | 20.1 | |
Diffuse | 0.9 | |
Number of Lesions | One | 24.2 |
Multiple | 11.2 | |
Location of lesions | Central | 7.1 |
Peripheral | 35.4 | |
Other findings | Lymphadenopathy | 0.3 |
Effusion | 0.3 |